Ardea Biosciences, Inc./DE (RDEA) is a publicly traded company in the Unknown sector. Across all available filings, 20 corporate insiders have executed 300 transactions totaling $95.1M, demonstrating a bullish sentiment with $70.4M in net insider flow. The most recent transaction on Jun 19, 2012 involved a transaction of 4,409 shares valued at $141.1K.
No significant insider buying has been recorded for RDEA in the recent period.
No significant insider selling has been recorded for RDEA in the recent period.
Based on recent SEC filings, insider sentiment for RDEA is bullish with an Insider Alignment Score of 87/100 and a net flow of $70.4M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Ardea Biosciences, Inc./DE (RDEA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 20 insiders are actively trading RDEA stock, having executed 300 transactions in the past 90 days. The most active insider is Julian Baker (Executive), who has made 17 transactions totaling $258.7M.
Get notified when executives and directors at RDEA file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jun 19, 2012 | W. Beck John | Executive | Disposition | 4,409 | $32.00 | $141.1K | |
| Jun 19, 2012 | Davis Stephen | Executive | Disposition | 16,099 | $32.00 | $515.2K | Large |
| Jun 19, 2012 | J. Fuchs Henry | Executive | Disposition | 10,416 | $32.00 | $333.3K | |
| Jun 19, 2012 | T. Hagerty David | Executive | Disposition | 140 | $32.00 | $4.5K | |
| Jun 19, 2012 | D. Quart Barry | Executive | Disposition | 43,348 | $32.00 | $1.4M | Large |
| Jun 19, 2012 | C. Tang Kevin | Executive | Disposition | 3,733,582 | $32.00 | $119.5M | Large |
| Jun 19, 2012 | C. Tang Kevin | Executive | Disposition | 15,089 | $32.00 | $482.8K | |
| Jun 19, 2012 | C. Tang Kevin | Executive | Disposition | 67,052 | $32.00 | $2.1M | Large |
| Jun 19, 2012 | Manhard Kimberly | Executive | Option Exercise | 2,906 | $14.95 | $43.4K | |
| Jun 19, 2012 | Manhard Kimberly | Executive | Option Exercise | 4,375 | $5.95 | $26.0K | |
| Jun 19, 2012 | Manhard Kimberly | Executive | Option Exercise | 5,548 | $15.69 | $87.0K | |
| Jun 19, 2012 | Manhard Kimberly | Executive | Sale | 12,829 | $31.96 | $410.0K | |
| Jun 19, 2012 | Manhard Kimberly | Executive | Disposition | 10,200 | $32.00 | $326.4K | |
| Jun 19, 2012 | Baker Julian | Executive | Disposition | 99,636 | $32.00 | $3.2M | Large |
| Jun 19, 2012 | Baker Julian | Executive | Disposition | 2,302 | $32.00 | $73.7K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Disposition(D) | 16 | $346.1M | 77.7% |
Purchase(P) | 40 | $82.7M | 18.6% |
Sale(S) | 100 | $12.3M | 2.8% |
Exercise(M) | 100 | $3.8M | 0.8% |
Payment(F) | 15 | $126.1K | 0.0% |
Award(A) | 5 | $102.4K | 0.0% |
Gift(G) | 12 | $0 | 0.0% |
Other(J) | 6 | $0 | 0.0% |
Exercise (Options)(X) | 1 | $0 | 0.0% |
Conversion(C) | 5 | $0 | 0.0% |
Insiders at Ardea Biosciences, Inc./DE are accumulating shares at an accelerated pace. With 20 insiders making 300 transactions totaling $82.7M in purchases versus $12.3M in sales, the net buying activity of $70.4M signals strong executive confidence. Julian Baker (Executive) leads the buying activity with $258.7M in transactions across all time.